R&D expenditure of new therapeutic drugs 2009-2018

Published by
Matej Mikulic,
Jun 1, 2022
Expected R&D expenditure on new therapeutic agents in the dermatology area averaged at nearly two billion U.S. dollars in the period between 2009 and 2018. This statistic describes the mean and median R&D expenditure for new agents approved by the FDA, by therapeutic area.

Mean and median R&D expenditure on new drugs by therapeutic area between 2009 and 2018* (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

March 2020

Region

United States

Survey time period

2009 to 2018

Supplementary notes

* Expected expenditure for new therapeutic agents approved by the Food and Drug Administration (FDA).
Therapeutic areas were obtained from the anatomical therapeutic chemical classification system database. Where agents were not yet classified, the categorization was based on the approved indication.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Clinical trials "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Clinical trials

R&D overview

6

Top R&D companies

5

Clinical studies

7

Participation

4

Costs and market

6

Approvals, launches, setbacks

6

COVID-19

4

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Clinical trialsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu